| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.002 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.00083 | 1 |